Found: 11
Select item for more details and to access through your institution.
Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotides.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03132-2
- By:
- Publication type:
- Article
Protein production and induction of the unfolded protein response in Trichoderma reesei strain Rut-C30 and its transformant expressing endoglucanase I with a hydrophobic tag.
- Published in:
- Biotechnology & Bioengineering, 2005, v. 89, n. 3, p. 335, doi. 10.1002/bit.20350
- By:
- Publication type:
- Article
Primary recovery of a genetically engineered Trichoderma reesei endoglucanase I (Cel 7B) fusion protein in cloud point extraction systems.
- Published in:
- Biotechnology & Bioengineering, 2002, v. 78, n. 4, p. 385, doi. 10.1002/bit.10232
- By:
- Publication type:
- Article
Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08852-4
- By:
- Publication type:
- Article
A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-01728-8
- By:
- Publication type:
- Article
Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease.
- Published in:
- Cardiovascular Research, 2023, v. 119, n. 7, p. 1596, doi. 10.1093/cvr/cvad039
- By:
- Publication type:
- Article
Rationale and design of ENDEAVOR: A sequential phase 2b–3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1696, doi. 10.1002/ejhf.2977
- By:
- Publication type:
- Article
Relationship of Soluble Lectin-Like Low-Density Lipoprotein Receptor-1 (sLOX-1) With Inflammation and Coronary Plaque Progression in Psoriasis.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 22, p. 1, doi. 10.1161/JAHA.123.031227
- By:
- Publication type:
- Article
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 3, p. 1, doi. 10.1161/JAHA.122.027540
- By:
- Publication type:
- Article
Secular trends in cardiovascular risk factors among women aged 45-54 years in Gothenburg, Sweden, from 1980 to 2014.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Identification of RNA-binding proteins in exosomes capable of interacting with different types of RNA: RBP-facilitated transport of RNAs into exosomes.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195969
- By:
- Publication type:
- Article